Danit Ariel is an Endocrinology/Metabolic physician affiliated with Stanford Medicine. OpenAlex indexes 30 publications with 1,079 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 15 Apr 2024.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
53.3%l-Thyroxine53.3%Levothyroxine Sodium100%Part D<11 patientsGenitourinary & hormones
46.7%Androgen46.7%Testosterone Cypionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Approach to the patient: cases of hormonal management in older transgender and gender diverse adults
The Journal of Clinical Endocrinology & Metabolism
2026 - Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States
The Journal of Clinical Endocrinology & Metabolism
2025 - A call to action: Advancing research, practice, and policy for middle aged and older transgender and nonbinary communities
International Journal of Transgender Health
2025 - A review of menopause in transgender and gender diverse individuals
Current Opinion in Obstetrics & Gynecology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Ranjana Advani, MD
Stanford Medicine
Michael Weisman, MD
Stanford Medicine
Maurice Ohayon, MD, DSC, PhD
Stanford Medicine
Bruno Medeiros, MD
Stanford Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”